Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No. Never owned NGEN. Just noticed DTCC clearance and wondered
if it might be going up.
Hey man, are you still holding here? I think we need to bring this one back to life...
NGEN SEC Suspension:
http://www.sec.gov/litigation/suspensions/2014/34-71242.pdf
Order:
http://www.sec.gov/litigation/suspensions/2014/34-71242-o.pdf
Admin Proceeding:
http://www.sec.gov/litigation/admin/2014/34-71241.pdf
NGEN skull-bones.. I love these :) http://www.otcmarkets.com/stock/NGEN/company-info
That is with the RIGHT>>>> data
http://stockcharts.com/c-sc/sc?s=NGEN&p=d&b=3&g=0&id=p17970548896
sc
NGEN .005 update: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85699725
LOL...I'm out too!!!
Wow my sell went through, and its up 150 percent, dont get stuck...
Good luck...keep on watch list. I seen this before, possible maniputlation to pick up cheaper shares.
Well looks like a bust, im out of pinksheets for good now, back to big boards, glta.
Sellers are gone!!! Great volume for 10:45am!!
We blew through the vol. and moving averages!!!! This is more then a trade unfolding!!
Per last 13g Seth Hoogasian, is president of TMO, thermo fisher scientific, and it trades on nyse at 56.00 a share, and seth is the owner of ngen...
thermo fisher scientific inc
(TMO:New York)
Last $56.58 USD
Change Today 0.00 / 0.00%
Volume 0.0
TMO On Other Exchanges
As of 8:04 PM 08/6/12 All times are local (Market data is delayed by at least 15 minutes).
Snapshot
News
Charts
Financials
Earnings
People
Ownership
Transactions
Options
OverviewBoard MembersCommittees
Executive Profile*
Seth H. Hoogasian
Senior Vice President, General Counsel and Secretary, Thermo Fisher Scientific, Inc.
Age
Total Calculated Compensation
This person is connected to 0 board members in 1 different organizations across 3 different industries.
57
--
Background*
Mr. Seth H. Hoogasian has been Senior Vice President of Thermo Fisher Scientific, Inc. since November 2006 and as its Secretary since 2001 and General Counsel since 1992. Mr. Hoogasian also serves as Senior Vice President, Secretary and General Counsel of Fisher Scientific International Inc. Mr. Hoogasian has been the President of Dionex Corp. since May 17, 2011. He served as Vice President of Thermo Fisher Scientific, Inc. from 1996 to November 2006. He has been a Director ...
Read Full Background
Corporate Headquarters*
81 Wyman Street
Waltham, Massachusetts 02454
United States
Phone: 781-622-1000
Fax: 781-622-1207
Board Members Memberships*
2011-Present
President and Director
Dionex Corp.
Education*
There is no Education data available.
Other Affiliations*
Dionex Corp.
Fisher Scientific International Inc.
Annual Compensation*
There is no Annual Compensation data available.
Stock Options*
There is no Stock Options data available.
Total Compensation*
There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
Report Data Issue
Common sense would suggest, that something is happening w the record volume.
Cool...Post all your findings...I will do the same!!! :)
Do you know what company?
NGEN is connected to a $56.00 a share stock on the NYSE. Something big is coming, hold on to your hats....
Good be....its something good!!!!
R/M is what it looks like....
NGEN Inc (NGEN.PK)
Related Topics:
Stocks
Stock Screener
Market Data
Overview
News
Key Developments
People
Charts
Financials
Options
Analysts
Research
Pulse
NGEN.PK on OTC Markets Group - (No Information)
0.00USD
2:54pm EDT
Price Change (% chg)
$0.00(+122.22%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.01
Day's Low
$0.00
Volume
2,221,882
Avg. Vol
9,339
52-wk High
$0.02
52-wk Low
$0.00
NGEN.PK
About
Ngen, Inc., formerly Nanogen, Inc., is a diagnostics company with the mission to make the detection, the diagnosis, and the treatment and monitoring of an individual’s health easier and faster. It participates in two markets. The first is the molecular diagnostics market where it offers assays for real-time polymerase chain... (more)
Buy/Sell
No analyst recommendations are available for NGEN.PK.
» Analyst Consensus
Overall
Beta:
0.41
Market Cap (Mil.):
$0.15
Shares Outstanding (Mil.):
82.30
Dividend:
--
Yield (%):
--
Its official, the most shares ever traded on this stock...Wonder whats up......
I've been waiting for this day.. excelllent entry price for the type of products they develop, Their patents are worth millions!
Loadin da boat.
If NGEN is trading, does it matter who owns it? If the PPS goes up the shareholders do receive something. I've owned this for years and I was stunned to see it finally moving. Anyway, they make real products, unlike some of the crap stocks I have owned. What's yesterday's move all about? I have no idea.
Can you tell me why the volume of the stock is up today and pps is rising?
Triforce, why do you post all this nonsense? Nanogen does not exist (it's just a shell). All assets were sold to Elitech. Shareholders will receive nothing.
Visit us at CVS
http://epochbio.com/news_and_events/press_releases/5434.html
2011-05-02
Come see us at CVS May 8 - 11th at Daytona Beach. Booth 439
http://www.wescor.com/newsletter/cvs/
must be an issue with my firm this morning, thanks for the info
Level II 10:50 (all normal)
BID:
NITE 0.012 50
UBSS 0.0113 50
CSTI 0.0102 50
VNDM 0.009 50
DOMS 0.0077 50
STXG 0.0057 50
LAFC 0.0057 50
MAXM 0.005 50
HDSN 0.004 50
ETMM 0.0001 50
ASK:
ETMM 0.0139 50
NITE 0.014 50
UBSS 0.015 50
CSTI 0.017 50
AUTO 0.017 50
HDSN 0.02 50
STXG 0.03 50
DOMS 0.05 50
MAXM 0.1 50
VNDM 1 25
my brokerage account is showing no bid and no ask for NGEN today, strange...
Global Cardiovascular Disease Diagnostics Market to Reach US$12.4 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
San Jose, CA (Vocus/PRWEB) February 23, 2011
Major players profiled in the report include Abbott Diagnostics, Alere Inc., Beckman Coulter, Inc., Cholestech Corp., GE HealthCare, Nanogen Inc., Philips Medical Systems, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., St Jude Medical Inc., among others.
http://www.prweb.com/releases/cardiovascular_disease/diagnostics_in_vitro_vivo/prweb8153547.htm
Mr. Ludvigson is also a Director of China Stem Cells Ltd. Mr. Ludvigson received a B.S. and an M.A.S. from the University of Illinois
©2011 Nanogen, Inc. — All rights reserved.
http://epochbio.com/
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
232
|
Created
|
03/18/04
|
Type
|
Free
|
Moderators |
New url http://www.epochbio.com/ ©2011 Nanogen, Inc. — All rights reserved. (Old url http://www.nanogen.com/)
PARIS, FRANCE – June 25, 2009 – The ELITech Group, a French privately held group of companies and worldwide manufacturer and distributor of in vitro diagnostic equipment and reagents, announces that an order has been entered in the Bankruptcy Court of the District of Delaware approving its acquisition of substantially all of the assets of Nanogen, Inc. (Pink Sheets: NGEN), Epoch Biosciences, Inc., and Nanotronics, Inc., including Nanogen Advanced Diagnostics S.r.l., a wholly-owned subsidiary of Nanogen, Inc., under the terms of an asset purchase agreement dated May 13, 2009. This court order now clears the way for ELITech to complete the acquisition of Nanogen and, subject to customary closing conditions, the parties expect to close the transaction on or about June 30, 2009.
http://www.elitechgroup.com/en/news/elitech-acquires-nanogen-s-asset
Based in Italy, Nanogen Advanced Diagnostics (NAD) is a wholly owned subsidiary of Elitech Group and the European base of operations. NAD and has been active as a supplier of advanced diagnostic products since the early 1990s when it began commercializing molecular diagnostic reagents.
The ELITech Group (http://www.elitechgroup.com) is a high-growth, profitable in vitro diagnostics company with global sales and distribution capabilities in over 100 countries. The group offers clinical chemistry, microbiology, immunology and electrophoresis products and operates globally, leveraging products from its own clinical chemistry and microbiology equipment and reagents facilities in Europe and North America, as well as complementary third-party products. In May 2007, the ELITech Group acquired Wescor, Inc., Utah (http://www.wescor.com) to broaden its biomedical product platform and to provide a base for business expansion in North America. In October 2007, the ELITech Group acquired Vital Scientific B.V. in the Netherlands to allow the group to offer a complete clinical chemistry solution. The ELITech Group plans to actively pursue its external growth strategy in the coming years.
For additional information, please contact Pierre Debiais :
(tel. +33 (0) 1 41 45 07 10).
SYN Biotechnology; is the ONLY authorized vendor all across the country among the distributor of Applied Biosystems, Nanogen Advanced Diagnostic, Prionics AG, Molgentix products.
http://www.synbio.com.tr/en_index.php
PARIS, FRANCE – January 26, 2010 – The ELITech Group, a privately held group of companies and worldwide manufacturer and distributor of in vitro diagnostic equipment and reagents, announces that its Epoch Bioscience division of Wescor, Inc has sold the intellectual property and tangible assets associated with its electronic microarray technology, previously acquired as part of the ELITech Nanogen asset purchase, to the Gamida For Life Group. The microarray technology includes all properties associated with the so-called NC400 electronic microarray product line."Our NC400 technology is an important nucleic acid profiling platform with particular applications in single nucleotide polymorphism applications. The microarray technology will be developed and applied within the Gamida for Life Group principally by Gamidor Diagnostics and Savyon Diagnostics, who are strong diagnostic solution providers with a growing molecular diagnostics presence. The Gamida for Life Group has developed a variety of focused applications for the NC400 and we believe that our divestiture of these former Nanogen assets to it will allow the full and appropriate realization of the potential for this cutting-edge technology.
The asset sale allows ELITech to remain focused on our core strengths and gives us the ability to enhance our presence in molecular diagnostics through our attention on real-time PCR relationship", said Pierre Debiais, the ELITech Group's President and founder.
The ELITech Group has become a major player in the international medical market. The Elitech Group has brought together IVD specialty companies to provide the best offering of innovative, unique and also routine products to laboratories operating closer to the patient. It comprises:
- Vital Scientific and Seppim which manufacture a full range of clinical chemistry analyzers and reagents;
- ELITech Microbio (former International Microbio) which manufactures microbiology kits;
- Wescor which manufactures unique laboratory instruments such as strainers and sweat test devices;
- inoDiag which manufactures a unique multiplex serology device;
- Nanogen which manufactures leading edge technology molecular biology kits;
- SERFIB which develops and manufactures well established microbiology and immunology kits such as reagents for the detection of parasites and rheumatoid factors. Through direct sales in Europe and North America and distribution capabilities in over 100 countries, the ELITech Group offers clinical chemistry, microbiology, immunology and molecular biology products from its own facilities as well as complementary third-party products see www.elitechgroup.com.
Gamida for Life is a privately-owned international group of companies dedicated to the healthcare field. The principal holding company is Gamida for Life BV of the Hague, the Netherlands. Through subsidiaries in Bulgaria, France, Israel, Turkey, the United Kingdom and elsewhere and distribution networks worldwide, the Group markets, sells and services diagnostic systems, medical rquipment and devices and products for scientific research sourced both from its own development and manufacture and from leading international suppliers.
Gamida for Life site
Welcome to the Gamida for Life site.
The company forms part of the international Gamida for Life Group, which is privately-owned and dedicated to the healthcare field. The principal holding company is Gamida for Life BV of Rotterdam, the Netherlands.
In France, Gamida SA and its subsidiaries are engaged in the development and production of medical equipment and devices for sale in both the home market and abroad, as well as in the distribution in France of products from international suppliers.
In Israel, the Group's interests are more diverse. Medical equipment and devices, as well as pharmaceutical products, are distributed by Gamida-MedEquip Ltd, which also offers a specialized supply service to industrial critical environments. Danyel Biotech Ltd. distributes biotechnological products to research laboratories. Through GamidaGen Ltd. and GamidaSense Diagnostics Ltd, the latter being a joint venture with the principal scientists involved, the Group is engaged in the research, development, production and sale of diagnostic products. Volcano Ltd. has recently been established to develop and exploit technology in the same field. Gamida for Life BV is also the founding shareholder of Gamida Cell Ltd, which is developing new techniques for cell and gene therapy.
Healthcare researches, develops and produces in vitro diagnostic tests for sale worldwide under the SAVYON name. Healthcare has acquired two of the Group's major Israeli operations: Gamidor Ltd, which distributes product lines for research and industrial laboratories, and Gamidor Diagnostics, which supplies systems, instruments and reagents to clinical laboratories. It has also promoted a number of start-up research and development ventures, such as Glycodata Ltd. in the field of glycobiology.
Elsewhere, the Group's interests include distribution houses under the Gamidor name in Bulgaria and Turkey.
In addition, through Gamida for Life (Israel) Ltd, the Group is engaged in the development and dissemination of a range of educational tools for businesses, institutions and individuals in both Israel and the Palestinian autonomy.
Whenever needed, the Company is able to draw upon the knowledge and skills of colleagues throughout the Group, with whom close contact is maintained.
Gamidor Technical Services Ltd
Biomedical Services & Supplies
6 Hawksworth, Southmead Park
Didcot, Oxfordshire, OX11 7HR
United Kingdom
Tel: +44 (0)845 054 0616
Fax: +44 (0)845 054 0626
Email: service@gamidor.co.uk
http://www.gamidor.co.uk/gamida-for-life.html
Posting Rules for the NGEN board!
All posters will be subject to the IHub TOU agreement.
Any messages that violate the User Agreement or detracts from the civility of the board will be removed.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |